ОбзорГрафикПрофильОсновная статистикаФинансовые показателиНовостиTraderScreen

AEVIS VICTORIA SA/  CH0478634105  /

Turquoise
14.06.2024  13:41:21 Изменение +0.15 Объем сделки Бид- Предложение- Рыночная капитализация Дивидендная доходность Коэффициент Цена/Доход
15.90CHF +0.95% 14
Оборот: 222.60		 -Величина цены спроса: - -Величина цены предложения: - 1.36 млрдCHF - -
GlobeNewswire 14:35 Life Science Virtual Investor Forum Presentations Now Available for Online Viewing
GlobeNewswire 14:30 Lead Real Estate Co., Ltd Announces Voluntary Lock-up Restrictions for Management and Senior Officer...
GlobeNewswire 14:30 Tenneco's Monroe Intelligent Suspension-Equipped Rivian R1T Targeting New Heights in Saturday’s Pike...
GlobeNewswire 14:30 Great Pacific Gold Announces New High-Grade Assays at Comet Discovery Including 4m at 22.3 g/t Gold
GlobeNewswire 14:30 DigiAsia Corp. Announces Execution of Definitive Agreements for a Convertible Note Financing with He...
GlobeNewswire 14:30 Selectis Health Completes Sale of Archway Transitional Care Center in Georgia
GlobeNewswire 14:30 West Bancorporation, Inc. to Announce Quarterly Results, Hold Conference Call
GlobeNewswire 14:30 SEALSQ to Participate in Northland Growth Conference
TeleTrader 14:23 Baerbock to travel to Israel, West Bank, Lebanon
GlobeNewswire 14:15 Palisade Bio Provides Update on Advancement of its Strategic Collaboration with Strand Life Sciences
GlobeNewswire 14:05 Starton Therapeutics Announces 100% Partial Response or Better in Multiple Myeloma Patients in Inter...
GlobeNewswire 14:00 Lifetime Brands, Inc. Announces Results of 2024 Annual Meeting
GlobeNewswire 14:00 Super Hi Announces Changes to Executive Leadership and Board Composition
GlobeNewswire 14:00 TESSAN Announces Collaboration with NatGeo Explorer and Photographer Mattias Klum
GlobeNewswire 14:00 Bukit Jalil Global Acquisition 1 Ltd. Postponed the Extraordinary General Meeting to June 28, 2024 a...
GlobeNewswire 14:00 Pan American Energy Announces Completion of the Spring 2024 Field Prospecting and Sampling Program a...
GlobeNewswire 14:00 Landmark Nature Medicine Study Reports Promising New Treatment Reduces Suffering in Sanfilippo syndr...
GlobeNewswire 14:00 Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27
GlobeNewswire 14:00 Aprea Therapeutics to Host Virtual KOL Event on APR-1051, a Highly Selective and Potentially Best-in...
GlobeNewswire 14:00 Rectitude Holdings Ltd Announces Pricing of Initial Public Offering
GlobeNewswire 14:00 Ascent Solar Technologies Announces Debt Pay Off for Outstanding Balances
GlobeNewswire 14:00 Super League Issues Mid-Year Update, Expects Record 2024 Revenues
GlobeNewswire 14:00 Acasti Announces Year-End 2024 Financial Results, Provides Business Update
GlobeNewswire 14:00 Monarch Private Capital Releases 2023 Impact Report: “Touchpoints”
GlobeNewswire 14:00 Lexicon Pharmaceuticals Resubmits Sotagliflozin NDA for Type 1 Diabetes